Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Asset Writedowns and Impairment (2016 - 2025)

Haemonetics has reported Asset Writedowns and Impairment over the past 12 years, most recently at $9.3 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $9.3 million; the TTM value through Dec 2025 reached $17.9 million, up 3389.28%, while the annual FY2025 figure was $2.4 million, 77.05% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $9.3 million at Haemonetics, up from $8.6 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $20.9 million in Q2 2021 and troughed at $94000.0 in Q3 2022.
  • A 4-year average of $6.8 million and a median of $5.1 million in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 1046950.0% in 2021 and later tumbled 98.17% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $5.1 million in 2021, then tumbled by 98.17% to $94000.0 in 2022, then soared by 445.74% to $513000.0 in 2023, then skyrocketed by 1712.87% to $9.3 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for HAE at $9.3 million in Q4 2025, $8.6 million in Q3 2025, and $513000.0 in Q2 2023.